Pfizer-BioNTech COVID-19 Vaccine was authorized on December 9, 2020, for use in accordance with the Interim Order Respecting the Importation, Sale and Advertising of Drugs for Use in Relation to COVID-19 . Since the time of authorization, Pfizer-BioNTech has submitted data to Health Canada to support alternative temperature for transportation and storage conditions.
RecallTracker